---

An Analysis of the Pharmaceutical Industry Reveals a Corporate Elite Stranglehold on the American Health Care System. Be Aware That They Don’t Truly Care About You.

---

An analysis of pharmaceutical companies shows they are one of the most corrupt industries in the Unites States and around the world.

Pharmaceutical orgaaizations, directed by global elites, prey upon American citizens in an effort to control health.

There’s no doubt the pharmaceutical industry has contributed greatly to humanity, with major achievements to note; yet there is also no doubt its corruption is just as widespread.

Corporate crime can be found in pharmaceuticals as in any industry, but perhaps what makes it so incomprehensible is this is an industry that is supposed to be based on humanitarian behavior and goals.

One of the most corrupt practices is the paying of bribes to any level of government official that might have anything to do with the interests of the pharmaceutical company, such as getting drugs approved faster for marketing or for hospital administrators.

Even more of a concern than bribery is that those pharmaceutical corporations think nothing of being fraudulent in the area of public safety and testing of drugs.

Another problem with drug companies is how often they misrepresent medications in advertising, jeopardizing the purity of drugs without any regard for the outcome when trusting consumers use their products.

The possibilities for corruption and crime in the pharmaceutical industry are endless.

An analysis of pharmaceutical companies shows there will always be people who work in the industry with idealism and a genuine concern for people.

On the other hand, the pharmaceutical industry is a prime market for fraud and greed.

---

---

Analysis of Pharmaceutical Industry

One of the biggest concerns in the analysis of pharmaceutical companies is the covering up of drug side effects in order to pass drugs from the testing stage to consumer use.

Pharmaceutical cover up also happens when drug companies hide adverse drug reaction reports submitted by doctors.

In 1982, Eli Lilly, a leading drug company, was fined $25,000 in the United States after being charged for covering up the side effects and deaths caused by Oraflex, an anti-arthritic drug.

Lilly failed to warn doctors and consumers that side effects of Oraflex could damage the kidneys and liver.

What’s disturbing is Lilly just considered this a slap on the wrist as in 2007 they again attempted to cover up information about their drug Zyprexa, a drug used for schizophrenia and bipolar disorders.

Studies showed patients taking this drug could gain large amounts of weight, leading to obesity and risk for diabetes.

Lilly didn’t want this information released to doctors or consumers, thinking it might affect their sales.

Even after the FDA released reports warning of side effects from Zyprexa, Lilly still refused to release their own findings.

In January of 2007, Lilly ended up paying $500 million to settle 18,000 lawsuits as people claimed they had developed diabetes, and other health problems, after using Zyprexa.

Although $500 million may seem like a lot of money, to large pharmaceutical corporations who see billions of dollars in profits, this is just small punishment.

---

Regulating the Pharmaceutical Industry

One of the reasons the pharmaceutical industry is so regulated is there is so much room for corruption and fraud to occur.

Not only does there need to be regulation to safeguard against ineffective and dangerous drugs, regulation is also required in such a competitive market.

In order to ensure that economic competitiveness is there to benefit consumers with new medications and not to pad the pockets of corporate employees.

In the analysis of pharmaceutical corporations, it’s also been noted that the connection between doctors and drug companies is wide open for corruption.

Doctors are often offered commissions and kickbacks for prescribing certain drugs.

Doctors are also often called upon by pharmaceutical companies to recruit the so-called perfect patient for clinical trials.

This way test results, though accurate, are only taking into account ideal clinical conditions, which really makes the testing dangerous and unethical.

---

Aggresive Promotion of Drugs

Studies done in 2004 by York University researchers found pharmaceutical companies in the United States spend more money on promoting and marketing drugs than they do on research and development.

In fact, pharmaceutical marketing practices are often unethical.

Many doctors and pharmaceutical industry regulators are concerned drug companies aren’t following guidelines for marketing and advertising.

Many believe the guidelines need to be redrawn to protect consumers.

The pharmaceutical industry in the United States is probably no better or worse than in other developed countries, but this makes it far from okay.

American citizens need to be able to trust their doctors and other healthcare providers.

They need to be certain that medications they’re taking are safe and have passed testing fairly without influence from drug companies.

---

---